en
Doctoral thesis
English

The role of c-kit (CD117) and its crosstalk with integrins for controlling cell adhesion and spreading: implications for therapeutic resistance of leukaemia

Defense date2020-10-02
Abstract

Kit Ligand (KitL) or Stem Cell Factor (SCF) and its receptor tyrosine kinase, c-Kit (CD117) are critical for the survival of germ cells, melanocytes, hematopoietic stem cells and mastocytes. Overexpression and gain-of-function mutations of c-kit were detected in several human cancers such as leukemia. Despite treatments with tyrosine kinase inhibitors (TKIs) notably, imatinib, tumor cells persist in the tissue microenvironment of the bone marrow in an integrin-dependent manner. These resident tumor cells can cause the development of therapy resistance due to secondary mutations in c-Kit and tumor relapse. So far, it is not understood why tumor cells are sensitive to TKI inhibitors when present in the blood, but escape this treatment when anchored to their niche in the bone marrow.

eng
Keywords
  • C-kit
  • CD117
  • Integrin
  • Cell spreading
  • Cell adhesion
  • Tyrosine kinase receptor
  • Tyrosine kinase inhibitor
  • Imatinib
  • Dasatinib
  • Leukaemia
  • Crosstalk
Funding
  • Swiss National Science Foundation - 166384
Citation (ISO format)
CHEBBI-MATHLOUTHI, Seimia. The role of c-kit (CD117) and its crosstalk with integrins for controlling cell adhesion and spreading: implications for therapeutic resistance of leukaemia. 2020. doi: 10.13097/archive-ouverte/unige:153036
Main files (1)
Thesis
accessLevelRestricted
Identifiers
228views
6downloads

Technical informations

Creation07/11/2021 9:21:00 AM
First validation07/11/2021 9:21:00 AM
Update time06/20/2023 11:07:26 AM
Status update06/20/2023 11:07:26 AM
Last indexation01/29/2024 10:39:41 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack